Date: 5.2.2014
Technology request: A vaccine against Bovine Leukemia Virus
Reference: TOBE20131206001
Summary: A Belgian university team developed a recombinant Bovine Leukemia Virus (BLV) with attenuated phenotype and two specific mutations. Efficacy, persistence, safety and pathogenicity make this vaccine unique. The research team is looking for collaboration with companies interested in license agreement.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
ScienceWeek - Biotechnology Science since 1997
Biotechnology company - list of biotechnology companies
Nanozyme-enabled nanodecoys: A new strategy for fighting urinary tract infections
New molecule triggers burst of white blood cells to fight infections